Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Moderna Stock Is Up

TheMotleyFool

0 0

In this episode of Market Foolery, Chris Hill chats with Motley Fool analyst Emily Flippen about the latest headlines and earnings reports from Wall Street. Moderna (NASDAQ: MRNA) enters a new phase in its COVID-19 vaccine trials. A popular toymaker's stock gets a steep cut. Finally, the hosts answer some listener questions about portfolio allocation and retail investment in a post-COVID-19 world.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.

Source Fool.com

Like: 0

MRNA

Teilen